As of 2026-09-19, the Relative Valuation of Keros Therapeutics Inc (KROS) is (55.63) USD. This relative valuation is based on P/E multiples. With the latest stock price at 11.19 USD, the upside of Keros Therapeutics Inc based on Relative Valuation is -597.2%.
The range of the Relative Valuation is (100.01) - 0.38 USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 23.8x - 29.3x | 26.6x |
| Forward P/E multiples | 30.0x - 52.8x | 41.4x |
| Fair Price | (100.01) - 0.38 | (55.63) |
| Upside | -993.7% - -96.6% | -597.2% |
| Date | P/E |
| 2026-09-14 | -2.67 |
| 2026-09-11 | -2.64 |
| 2026-09-10 | -2.66 |
| 2026-09-09 | -2.69 |
| 2026-09-08 | -2.66 |
| 2026-09-04 | -2.69 |
| 2026-09-03 | -2.64 |
| 2026-09-02 | -2.67 |
| 2026-09-01 | -2.63 |
| 2026-08-31 | -2.64 |
| 2026-08-28 | -2.62 |
| 2026-08-27 | -2.67 |
| 2026-08-26 | -2.65 |
| 2026-08-25 | -2.78 |
| 2026-08-24 | -2.57 |
| 2026-08-21 | -2.62 |
| 2026-08-20 | -2.61 |
| 2026-08-19 | -2.64 |
| 2026-08-18 | -2.52 |
| 2026-08-17 | -2.49 |
| 2026-08-14 | -2.40 |
| 2026-08-13 | -2.54 |
| 2026-08-12 | -2.67 |
| 2026-08-11 | -2.53 |
| 2026-08-10 | -2.54 |
| 2026-08-07 | -2.65 |
| 2026-08-06 | -2.53 |
| 2026-08-05 | -2.38 |
| 2026-08-04 | -2.44 |
| 2026-08-03 | -2.41 |
| 2026-07-31 | -2.40 |
| 2026-07-30 | -2.43 |
| 2026-07-29 | -2.37 |
| 2026-07-28 | -2.40 |
| 2026-07-27 | -2.43 |
| 2026-07-24 | -2.39 |
| 2026-07-23 | -2.41 |
| 2026-07-22 | -2.43 |
| 2026-07-21 | -2.52 |
| 2026-07-20 | -2.52 |
| 2026-07-17 | -2.53 |
| 2026-07-16 | -2.52 |
| 2026-07-15 | -2.62 |
| 2026-07-14 | -2.52 |
| 2026-07-13 | -2.64 |
| 2026-07-10 | -2.81 |
| 2026-07-09 | -2.86 |
| 2026-07-08 | -2.78 |
| 2026-07-07 | -2.77 |
| 2026-07-06 | -2.62 |